Abstract
The influence of thyroid failure on hemostasis has been studied and is still not well understood. These patients have high risk for cardiovascular diseases because of the lipid metabolism and procoagulant agents. But the influence of thyroid failure on hemostasis is controversial. Tissue factor (TF) has an important role in the thromboembolic state. Recent experiments have demonstrated that TF-dependent activation of the coagulation cascade plays an important role in the pathophysiology of intravascular thrombus formation. The purpose of the present study was to investigate the contributions of TF, factor VII: C (FVII:C), factor XII:C (FXII:C), and fibrinogen in experimental hypothyroidism. TF was obtained from the thyroid gland and lung tissue of 10 rats following experimental hypothyroidism induced for 30 d and compared with similar tissue from 10 control rats. Significantly increased TF activities were found in hypothyroid rats. By contrast, FVII:C level was significantly decreased when compared with the control group. In this respect it is interesting to note that a hypercoagulable state due to increased thromboplastic activity may occur. Based on those results, elevated tissue factor activities (TFa) of the patients with low thyroid dysfunction may have another risk factor for cardiovascular diseases.
Similar content being viewed by others
References
Mammen, E. F. (1971). In: Thrombosis and bleeding disorders: Purification of tissue thromboplastin. Bang, N., Beller, F. K., Deutsch, E. and Mammen, E. F. (eds.). Academic: New York, London.
Rao, L. V., Rapaport, S. I., and Bajaj, S. P. (1986) Blood 68, 685–689.
Hathcock, J. (2004). Semin. Hematol. 41, 254–258.
Hasenstab, D., Lea, H., Hart, C. E., Lok, S., and Clowes, A. W. (2000). Circulation 101, 2651–2657.
Büyükçelik, A. and Akbulut, H. (2004). Turk. J. Haematol. 21, 7–11.
Bokarewa, M. I., Morrissey, J., and Tarkowski, A. (2002). Inflamm. Res. 51, 471–477.
Hembrough, T. A., Swartz, G. M., Papathanassiu, A., et al. (2003). Cancer Res. 63, 2997–3000.
Rapaport, S. I. and Rao, L. V. (1992). Arterioscler. Thromb. 12, 1111–1121.
Nawroth, P. P., Handley, D. A., Esmon, C. T., and Stern, D. M. (1986). Proc. Natl. Acad. Sci. USA, 83, 3460–3464.
Brox, J. H., Osterud, B., Bjorklid, E., and Fenton, J. W. (1984). Br. J. Haematol. 57, 239–246.
Crossman, D. C., Carr, D. P., Tuddenham, E. G., Pearson, J. D., and McVey, J. H. (1990) J. Biol. Chem. 265, 9782–9787.
Conway, E. M., Bach, R., Rosenberg, R. D., and Konigsberg, W. H. (1989). Thromb. Res. 53, 231–241.
Golino, P., Ragni, M., Cirillo, P., et al. (1996). Nat. Med. 2, 35–40.
Crutchley, D. J., Solomon, D. E., and Conanan, L. B. (1992). Arterioscler. Thromb. 12, 664–670.
Cappola, A. R. and Ladenson, P. W. (2003). J. Clin. Endocrinol. Metab. 88, 2438–2444.
Meier, C., Staub, J. J., Roth, C. B., et al. (2001). J. Clin. Endocrinol. Metab. 86, 4860–4866.
Gomberg-Maitland, M. and Frishman, W. H. (1998). Am. Heart. J. 135, 187–196.
Mya, M. M. and Aronow, W. S. (2002). J. Gerontol. A. Biol. Sci. Med. Sci. 57, 658–659.
Bruckert, E., Giral, P., Chadarevian, R., and Turpin, G. (1999). J. Cardiovasc. Risk. 6, 327–331.
Chadarevian, R., Bruckert, E., Leenhardt, L., Giral, P., Ankri, A., and Turpin, G. (2001). J. Clin. Endocrinol. Metab., 86, 732–737.
Chadarevian, R., Bruckert, E., Giral, P., and Turpin, G. (1999). Blood Coagul. Fibrinolysis 10, 481–486.
Muller, B., Tsakiris, D. A., Roth, C. B., Guglielmetti, M., Staub, J. J., and Marbet, G. A. (2001). Eur J. Clin. Invest. 31, 131–137.
Ford, H. C. and Carter, J. M. (1990). Postgrad. Med. J. 66, 280–284.
Rogers, J. S., Shane, S. R., and Jencks, F. S. (1982). Ann. Intern. Med. 97, 713–716.
Horne, M. K., Singh, K. K., Rosenfeld, K. G., et al. (2004). J. Clin. Endocrinol. Metab. 89, 4469–4473.
Hofbauer, L. C. and Heufelder, A. E. (1997). Eur. J. Endocrinol. 136, 1–7.
Myrup, B., Bregengard, C., and Faber, J. (1995). J. Intern. Med. 238, 59–63.
Tachman, M. L., and Guthrie, G. P. (1984). Endocr. Rev., 5, 456–465.
Dariyerli, N., Toplan, S., Akyolcu, M. C., Hatemi, H., and Yigit, G. (2004). Endocrine 25, 1–6.
Loeliger, E. A., Van Der Esch, B., Mattern, M. J., and Hemker, H. C. (1964). Thromb. Diath. Haemorrh. 10, 267–277.
Roberts, H. R., Monroe, D. M., and Maureane, H. (eds.) (2001). Williams hematology: molecular biology and biochemistry of the coagulation factor pathways of hemostasis. Academic, New York.
Marmur, J. D., Rossikhina, M., Guha, A. et al. (1993). J. Clin. Invest. 91, 2253–2259.
Annex, B. H., Denning, S. M., Channon, K. M. et al. (1995). Circulation 91, 619–622.
D'Andrea, D., Ravera, M., Golino, P., et al. (2003). Arterioscler. Thromb. Vasc. Biol. 23, 1684–1689.
Rickles, F. R., Patierno, S., and Fernandez, P. M. (2003). Chest 124, 58–68.
Versteeg H. H., Peppelenbosch, M. P., and Spek, C. A. (2003). Carcinogenesis 24, 1009–1013.
Danielsen, R., Onundarson, P. T., Thors, H., Vidarsson, B., and Morrissey, J. H. (1998). Scand. Cardiovasc. J. 32, 87–95.
Braat, E. A., Dooijewaard, G., and Rijken, D. C. (1999). Eur. J. Biochem., 263, 904–911.
Astrup, T., and Buluk, K. (1963). Circ. Res. 13, 253–260.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alturfan, A.A., Alturfan, E.E., Dariyerli, N. et al. Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism. Endocr 30, 63–67 (2006). https://doi.org/10.1385/ENDO:30:1:63
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:30:1:63